Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The *programmed cell death 10 pseudogene* (ENSG00000253340) is a genomic DNA sequence related to the protein-coding gene *programmed cell death 10* (PDCD10), but contains mutations or disruptions that render it non-functional in terms of protein coding. Like other pseudogenes, it does not produce a functional protein product. However, it may be transcribed into RNA, which could, in theory, play roles in gene regulation, such as acting as a competing endogenous RNA or through other non-coding RNA mechanisms[6][2]. There is no evidence that this pseudogene serves as a direct drug target, diagnostic biomarker, or therapeutic target, nor is it intrinsically associated with a molecular disease mechanism.
None (no drugs or direct targeting mechanisms described)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Programmed cell death 10 pseudogene (None).